Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. (2023)

First Author: Quick V
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kead604

PubMed Identifier: 37952183

Publication URI: http://europepmc.org/abstract/MED/37952183

Type: Journal Article/Review

Parent Publication: Rheumatology (Oxford, England)

ISSN: 1462-0324